Kazia Therapeutics Limited Profit Margin

The latest profit margin for KZIA is -1809.61% as of December 2025. That compares with -6443161.96% in the prior-year period — up 100.0% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Kazia Therapeutics Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, KZIA's profit margin moved from -6443161.96% to -1809.61% — a 100.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Kazia Therapeutics Limited's valuation or profitability profile.

Against Healthcare companies, KZIA currently prints -1809.61% for profit margin, while the sector average sits near 14.34%. That is roughly 12715.1% below the sector mean. Large gaps often invite a closer look at Kazia Therapeutics Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Kazia Therapeutics Limited converts resources into returns. At -1809.61%, KZIA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -6443161.96% in the prior-year period — up 100.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting KZIA's profit margin (-1809.61%), review year-over-year change from -6443161.96%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.